Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter E Lipsky

Showing results (31-40 of 271) with videos related to

Pageof 28
Sort By:
Nature Reviews. Rheumatology|January 19, 2021
Reply to: Diagnostic role of anti-dsDNA antibodies: do not forget autoimmune hepatitisDavid S Pisetsky, Peter E Lipsky
Immunology and Cell Biology|September 13, 2002
Dendritic cells, chemokine receptors and autoimmune inflammatory diseasesPetra D Cravens, Peter E Lipsky
Molecular Immunology|June 5, 2002
The kappa gene repertoire of human neonatal B cellsHermann J Girschick, Peter E Lipsky
Nature Reviews. Rheumatology|September 5, 2020
New insights into the role of antinuclear antibodies in systemic lupus erythematosusDavid S Pisetsky, Peter E Lipsky
Current Opinion in Rheumatology|August 24, 2022
Recent advances in the use of machine learning and artificial intelligence to improve diagnosis, predict flares, and enrich clinical trials in lupusKathryn M Kingsmore, Peter E Lipsky
Nature Clinical Practice. Rheumatology|September 5, 2006
Patient-centered outcomes: a bridge too far?Barbara B Mittleman, Peter E Lipsky
Current Protocols in Immunology|April 25, 2008
Isolation of human B cell populationsGary P Sims, Peter E Lipsky
Annals of the Rheumatic Diseases|April 18, 2024
Potential and pitfalls of repurposing the CAR-T cell regimen for the treatment of autoimmune diseaseAndrea R Daamen, Peter E Lipsky
Current Rheumatology Reports|September 10, 2004
Biomarkers in systemic lupus erythematosusGabor G Illei, Peter E Lipsky
Nature Reviews. Rheumatology|May 12, 2010
Microparticles as autoadjuvants in the pathogenesis of SLEDavid S Pisetsky, Peter E Lipsky
Pageof 28

Showing results (31-40 of 271) with videos related to

Sort By:
Pageof 28
Nature Reviews. Rheumatology|January 19, 2021
Reply to: Diagnostic role of anti-dsDNA antibodies: do not forget autoimmune hepatitisDavid S Pisetsky, Peter E Lipsky
Immunology and Cell Biology|September 13, 2002
Dendritic cells, chemokine receptors and autoimmune inflammatory diseasesPetra D Cravens, Peter E Lipsky
Molecular Immunology|June 5, 2002
The kappa gene repertoire of human neonatal B cellsHermann J Girschick, Peter E Lipsky
Nature Reviews. Rheumatology|September 5, 2020
New insights into the role of antinuclear antibodies in systemic lupus erythematosusDavid S Pisetsky, Peter E Lipsky
Current Opinion in Rheumatology|August 24, 2022
Recent advances in the use of machine learning and artificial intelligence to improve diagnosis, predict flares, and enrich clinical trials in lupusKathryn M Kingsmore, Peter E Lipsky
Nature Clinical Practice. Rheumatology|September 5, 2006
Patient-centered outcomes: a bridge too far?Barbara B Mittleman, Peter E Lipsky
Current Protocols in Immunology|April 25, 2008
Isolation of human B cell populationsGary P Sims, Peter E Lipsky
Annals of the Rheumatic Diseases|April 18, 2024
Potential and pitfalls of repurposing the CAR-T cell regimen for the treatment of autoimmune diseaseAndrea R Daamen, Peter E Lipsky
Current Rheumatology Reports|September 10, 2004
Biomarkers in systemic lupus erythematosusGabor G Illei, Peter E Lipsky
Nature Reviews. Rheumatology|May 12, 2010
Microparticles as autoadjuvants in the pathogenesis of SLEDavid S Pisetsky, Peter E Lipsky
Pageof 28